These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 28304156)
21. Theoretical studies on the inhibition mechanism of cyclooxygenase-2. Is there a unique recognition site? Soliva R; Almansa C; Kalko SG; Luque FJ; Orozco M J Med Chem; 2003 Apr; 46(8):1372-82. PubMed ID: 12672237 [TBL] [Abstract][Full Text] [Related]
22. The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition. Palermo G; Favia AD; Convertino M; De Vivo M ChemMedChem; 2016 Jun; 11(12):1252-8. PubMed ID: 26593700 [TBL] [Abstract][Full Text] [Related]
23. Molecular dynamics simulations of arachidonic acid complexes with COX-1 and COX-2: insights into equilibrium behavior. Furse KE; Pratt DA; Porter NA; Lybrand TP Biochemistry; 2006 Mar; 45(10):3189-205. PubMed ID: 16519514 [TBL] [Abstract][Full Text] [Related]
24. Structural basis of the dynamic mechanism of ligand binding to cyclooxygenase. Llorens O; Perez JJ; Palomer A; Mauleon D Bioorg Med Chem Lett; 1999 Oct; 9(19):2779-84. PubMed ID: 10522690 [TBL] [Abstract][Full Text] [Related]
25. Structural basis of enantioselective inhibition of cyclooxygenase-1 by S-alpha-substituted indomethacin ethanolamides. Harman CA; Turman MV; Kozak KR; Marnett LJ; Smith WL; Garavito RM J Biol Chem; 2007 Sep; 282(38):28096-105. PubMed ID: 17656360 [TBL] [Abstract][Full Text] [Related]
26. Molecular modelling of the differential interaction between several non-steroidal anti-inflammatory drugs and human prostaglandin endoperoxide H synthase-2 (h-PGHS-2). Pouplana R; Lozano JJ; Ruiz J J Mol Graph Model; 2002 Jan; 20(4):329-43. PubMed ID: 11858641 [TBL] [Abstract][Full Text] [Related]
27. Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: use of genetic function approximation. Zambre AP; Ganure AL; Shinde DB; Kulkarni VM J Chem Inf Model; 2007; 47(2):635-43. PubMed ID: 17256838 [TBL] [Abstract][Full Text] [Related]
29. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors. Gierse JK; McDonald JJ; Hauser SD; Rangwala SH; Koboldt CM; Seibert K J Biol Chem; 1996 Jun; 271(26):15810-4. PubMed ID: 8663121 [TBL] [Abstract][Full Text] [Related]
30. Comparison of cyclooxygenase-1 crystal structures: cross-talk between monomers comprising cyclooxygenase-1 homodimers. Sidhu RS; Lee JY; Yuan C; Smith WL Biochemistry; 2010 Aug; 49(33):7069-79. PubMed ID: 20669977 [TBL] [Abstract][Full Text] [Related]
31. The structural and electronical factors that contribute affinity for the time-dependent inhibition of PGHS-1 by indomethacin, diclofenac and fenamates. Pouplana R; Pérez C; Sánchez J; Lozano JJ; Puig-Parellada P J Comput Aided Mol Des; 1999 May; 13(3):297-313. PubMed ID: 10216835 [TBL] [Abstract][Full Text] [Related]
32. Three-dimensional structure of human cyclooxygenase (hCOX)-1. Miciaccia M; Belviso BD; Iaselli M; Cingolani G; Ferorelli S; Cappellari M; Loguercio Polosa P; Perrone MG; Caliandro R; Scilimati A Sci Rep; 2021 Feb; 11(1):4312. PubMed ID: 33619313 [TBL] [Abstract][Full Text] [Related]
33. Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines. Mandal P; Kundu BK; Vyas K; Sabu V; Helen A; Dhankhar SS; Nagaraja CM; Bhattacherjee D; Bhabak KP; Mukhopadhyay S Dalton Trans; 2018 Jan; 47(2):517-527. PubMed ID: 29235601 [TBL] [Abstract][Full Text] [Related]
34. Fluorescence quenching analysis of the association and dissociation of a diarylheterocycle to cyclooxygenase-1 and cyclooxygenase-2: dynamic basis of cyclooxygenase-2 selectivity. Lanzo CA; Sutin J; Rowlinson S; Talley J; Marnett LJ Biochemistry; 2000 May; 39(20):6228-34. PubMed ID: 10821698 [TBL] [Abstract][Full Text] [Related]
35. Profiling the interaction of 1-phenylbenzimidazoles to cyclooxygenases. Gómez-Castro CZ; López-Martínez M; Hernández-Pineda J; Trujillo-Ferrara JG; Padilla-Martínez II J Mol Recognit; 2019 Nov; 32(11):e2801. PubMed ID: 31353677 [TBL] [Abstract][Full Text] [Related]
36. Syntheses and characterization of nimesulide derivatives for dual enzyme inhibitors of both cyclooxygenase-1/2 and 5-lipoxygenase. Li Y; Chen SH; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS Bioorg Med Chem; 2011 Mar; 19(6):2074-83. PubMed ID: 21349729 [TBL] [Abstract][Full Text] [Related]
37. A computational prospect to aspirin side effects: aspirin and COX-1 interaction analysis based on non-synonymous SNPs. Marjan MN; Hamzeh MT; Rahman E; Sadeq V Comput Biol Chem; 2014 Aug; 51():57-62. PubMed ID: 24953043 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of linear phenylethynylbenzenesulfonamide regioisomers as cyclooxygenase-1/-2 (COX-1/-2) inhibitors. Anana R; Rao PN; Chen QH; Knaus EE Bioorg Med Chem; 2006 Aug; 14(15):5259-65. PubMed ID: 16635574 [TBL] [Abstract][Full Text] [Related]
39. Differential binding mode of diverse cyclooxygenase inhibitors. Llorens O; Perez JJ; Palomer A; Mauleon D J Mol Graph Model; 2002 Mar; 20(5):359-71. PubMed ID: 11885959 [TBL] [Abstract][Full Text] [Related]
40. In vitro COX-1 and COX-2 enzyme inhibitory activities of iridoids from Penstemon barbatus, Castilleja tenuiflora, Cresentia alata and Vitex mollis. Ramírez-Cisneros MÁ; Rios MY; Aguilar-Guadarrama AB; Rao PP; Aburto-Amar R; Rodríguez-López V Bioorg Med Chem Lett; 2015 Oct; 25(20):4505-8. PubMed ID: 26351040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]